Healthcare - Biotechnology - NASDAQ - US
$ 2.74
-5.19 %
$ 105 M
Market Cap
-2.8
P/E
Price Target
Average
100.73%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
20.06%
Net Income
Estimate
27.40%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Leap Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for LPTX of $5.5 , with forecasts ranging from a low of $5.5 to a high of $5.5 .
LPTX Lowest Price Target
Wall Street Target
5.5 USD
100.73%
LPTX Average Price Target
Wall Street Target
5.5 USD
100.73%
LPTX Highest Price Target
Wall Street Target
5.5 USD
100.73%
REVENUE FORECAST
Revenue Forecast Chart LPTX
EBIT FORECAST
EBIT Forecast Chart LPTX
NET INCOME FORECAST
Net Income Chart LPTX